Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act

BONE MARROW TRANSPLANTATION

卷 45, 期 3, 页码 419-421

NATURE PUBLISHING GROUP

-

Biophysics Oncology Hematology Immunology Transplantation